GLOBALink | Biomedical firms whitelisted in Shanghai resume work

**This is a 60-seconds sample of the video. For the full version, please contact us.**

GLOBALink | Biomedical firms whitelisted in Shanghai resume work

STORY: Biomedical firms whitelisted in Shanghai resume work DATELINE: May 25, 2022 LENGTH: 0:01:04 LOCATION: SHANGHAI, China CATEGORY: HEALTH SHOTLIST: 1. Fosun Kite Biotechnology Co., Ltd. 2. CanSino (Shanghai) Biological Research Co., Ltd. 3. SOUNDBITE 1 (Chinese): LIU QUAN, Associate director, CanSino (Shanghai) Biological Research Co., Ltd. 4. SOUNDBITE 2 (Chinese): WANG HAOMENG, Deputy general manager, CanSino (Shanghai) Biological Research Co., Ltd. STORYLINE: COVID-hit Shanghai has whitelisted some companies to support their resumption of work. Fosun Kite Biotechnology Co., Ltd. is among the first batch approved to resume operation. Production has fully restarted with 140 workers back to their positions. The factory produces Yescarta, a CAR-T therapy to treat certain types of large B-cell lymphoma. Shanghai subsidiary of Chinese vaccine developer CanSino Biologics Inc. has also resumed operation. The company gained approval to launch clinical trials for its experimental COVID-19 mRNA vaccine i

  • Product Code
  • ILEA000969382
  • Registered date
  • 2022/5/26 00:00:00
  • Credit
  • Xinhua / Kyodo News Images
  • Media source
  • Xinhua News Agency.All Rights Reserved
  • Media size
  • 1920 × 1080 pixel
  • Deployment size
  • 46.31(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos